Cargando…
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
The recent emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has posed formidable challenges for clinical laboratories seeking reliable laboratory diagnostic confirmation. The swift advance of the crisis in the United States has led to Emergency Use Authorization...
Autores principales: | Basu, Atreyee, Zinger, Tatyana, Inglima, Kenneth, Woo, Kar-mun, Atie, Onome, Yurasits, Lauren, See, Benjamin, Aguero-Rosenfeld, Maria E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383552/ https://www.ncbi.nlm.nih.gov/pubmed/32471894 http://dx.doi.org/10.1128/JCM.01136-20 |
Ejemplares similares
-
Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023) -
Dacron swab and PBS are acceptable alternatives to flocked swab and viral transport media for SARS-CoV-2
por: Kline, Ahnika, et al.
Publicado: (2021) -
Nasal Swab Performance by Collection Timing, Procedure, and Method of Transport for Patients with SARS-CoV-2
por: Callahan, Cody, et al.
Publicado: (2021) -
How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory
por: Thwe, Phyu M., et al.
Publicado: (2020) -
Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)